Aayush Wellness Launches Himalayan Shilajit Drops, Expands Nutraceutical Range
The addition complements Aayush Wellness's supplements across sleep, immunity, gut health, liver care, respiratory wellness and metabolic health. Its broader distribution strategy includes smaller Indian cities, digital channels and e-commerce
✨ महत्त्वाचे मुद्दे
Aayush Wellness Limited has launched Himalayan Shilajit Drops, entering the Shilajit-based wellness and vitality supplement category as it broadens its nutraceutical portfolio. Its shares were trading 0.54 per cent higher on November 16, 2026. The launch extends the company's condition-specific supplement range while supporting its plans to explore domestic and international growth opportunities.
The product contains Himalayan-sourced Shilajit extract in a liquid-drop format and is positioned around daily energy, stamina and vitality support. The company described the formulation as rich in fulvic acid and minerals and said it undergoes heavy-metal testing. It is offering the drops as a convenient alternative to conventional Shilajit formats.
Market estimates cited by Aayush Wellness put the global Shilajit market at USD 206.64 million in 2025, with a projection of USD 436.72 million by 2034. That implies a compound annual growth rate of about 8.67 per cent during 2026–2034. Liquid formulations accounted for approximately 60.72 per cent of the market in 2025, indicating an established market for the chosen delivery format.
Overseas, the company plans to explore Southeast Asian opportunities through its wholly owned Singapore subsidiary. That entity had not commenced operations as at March 31, 2026. Potential product introductions, including Shilajit Drops, remain subject to applicable regulatory and market-entry requirements.
The portfolio expansion follows rapid growth but slower profit progression. Consolidated revenue from operations rose 112 per cent to Rs 155.48 crore in FY2025-26, while profit after Tax increased 18.3 per cent to Rs 3.98 crore. Net margin, measured against total income, narrowed to about 2.5 per cent from 4.6 per cent. Management attributed the compression to launch marketing, distribution expansion and early investment in its diagnostics business, Aayush Labs.
As of 11.35 am on November 16, 2026, Aayush Wellness shares were trading at Rs 29.78. The stock had declined 57.25 per cent over the preceding year and remained well below its 52-week high of Rs 66.90. That performance provides a subdued market backdrop to the portfolio expansion, rather than evidence that product additions alone have changed the company's earnings trajectory or the stock's longer-term performance.
Can Aayush Wellness Turn Portfolio Expansion Into Profitable Growth?
Shilajit Drops gives Aayush Wellness another product to sell through its planned distribution expansion. The liquid format participates in an established category, so execution will depend on differentiation, consumer trust and repeat purchases rather than format novelty alone. Singapore offers a potential route into Southeast Asia, but regulatory clearances and commercial distribution must precede a meaningful overseas earnings contribution.
For investors, the launch is strategically supportive but does not by itself establish stronger profitability. The next test is whether additional products generate enough gross profit to absorb marketing and channel-building costs. Cash conversion also matters. FY2025-26 operating cash flow was negative Rs 0.72 crore, while unsecured borrowings rose to Rs 4.74 crore. Evidence of repeat demand, improving margins and cash generation would make portfolio breadth more financially meaningful over the medium term.
Disclaimer: The article is for informational purposes only and not investment advice.
